107 related articles for article (PubMed ID: 34816680)
1. Prevalence, Pattern, and Correlates of Polypharmacy among Iranian Type II Diabetic Patients: Results from Pars Cohort Study.
Azadi M; Kamalipour A; Molavi Vardanjani H; Poustchi H; Taherifard E; Sharifi MH; Salehi A; Mohammadi Z
Arch Iran Med; 2021 Sep; 24(9):657-664. PubMed ID: 34816680
[TBL] [Abstract][Full Text] [Related]
2. Population-based pattern of medication use and prevalence of polypharmacy among patients with cardiovascular diseases: results of the Pars cohort study from Iran.
Mohsenzadeh P; Ardekani A; Poustchi H; Mohammadi Z; Abdipour Mehrian SR; Bazrafshan Drissi H; Rahimian Z; Taherifard E; Nabavizadeh A; Kamalipour A; Mesgarpour B; Malekzadeh F; Molavi Vardanjani H
BMC Cardiovasc Disord; 2022 Oct; 22(1):435. PubMed ID: 36203125
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Correlates of Polypharmacy, and Drug Utilization Pattern in a Semi-urban Population: Results from the Pars Cohort Study.
Akbari MR; Kamalipour A; Pakroo M; Mesgarpour B; Poustchi H; Mohammadi Z; Gandomkar A; Molavi Vardanjani H
Arch Iran Med; 2023 Mar; 26(3):156-165. PubMed ID: 37543938
[TBL] [Abstract][Full Text] [Related]
4. Polypharmacy and pattern of medication use among patients with gastroesophageal reflux disease: results from Pars Cohort study.
Ghamar-Shooshtari A; Rahimian Z; Poustchi H; Mohammadi Z; Mesgarpour B; Akbari M; Kamalipour A; Abdipour-Mehrian SR; Hashemi ES; Zare P; Lankarani KB; Malekzadeh R; Malekzadeh F; Vardanjani HM
BMC Gastroenterol; 2023 Dec; 23(1):439. PubMed ID: 38097949
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of Adult Diabetes Mellitus and its Correlates in Pars Cohort Study in Southern Iran.
Akbarzadeh A; Salehi A; Molavi Vardanjani H; Poustchi H; Gandomkar A; Fattahi MR; Malekzadeh R
Arch Iran Med; 2019 Nov; 22(11):633-639. PubMed ID: 31823628
[TBL] [Abstract][Full Text] [Related]
6. Population-based prevalence of polypharmacy and patterns of medication use in southwestern Iran: A cross-sectional study.
Taherifard E; Mohammadi Z; Molavi Vardanjani H; Pakroo M; Emaminia M; Rahimi Z; Danehchin L; Abolnezhadian F; Malihi R; Paridar Y; Hariri S; Hashemi F; Cheraghian B; Mard A; Shayesteh AA; Poustchi H
Pharmacoepidemiol Drug Saf; 2022 May; 31(5):592-603. PubMed ID: 35187734
[TBL] [Abstract][Full Text] [Related]
7. The pattern of medication use, and determinants of the prevalence of polypharmacy among patients with a recent history of depressive disorder: results from the pars cohort study.
Ghaed-Sharaf M; Hariri S; Poustchi H; Nourollahi M; Khani S; Taherifard E; Mohammadi Z; Hadipour M; Sabaei R; Gandomkar A; Malekzadeh F; Vardanjani HM
BMC Psychol; 2022 Jan; 10(1):12. PubMed ID: 35042543
[TBL] [Abstract][Full Text] [Related]
8. The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years.
Guaraldi G; Malagoli A; Calcagno A; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Riva A; Focà E; Nozza S; Di Perri G
BMC Geriatr; 2018 Apr; 18(1):99. PubMed ID: 29678160
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and predictors of polypharmacy prescription among type 2 diabetes patients at a tertiary care department in Ningbo, China: A retrospective database study.
Li J; Chattopadhyay K; Xu M; Chen Y; Hu F; Wang X; Li L
PLoS One; 2019; 14(7):e0220047. PubMed ID: 31314797
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of anemia and its associated factors among patients with type 2 diabetes mellitus in a referral diabetic clinic in the north of Iran.
Hizomi Arani R; Fakhri F; Naeimi Tabiee M; Talebi F; Talebi Z; Rashidi N; Zahedi M
BMC Endocr Disord; 2023 Mar; 23(1):58. PubMed ID: 36894956
[TBL] [Abstract][Full Text] [Related]
11. The association of parity number with multimorbidity and polypharmacy among Iranian women in the Azarcohort: a cross-sectional study.
Faramarzi E; Somi MH; Tutunchi H; Almaspour H; Sanaie S; Asemani S
BMC Womens Health; 2023 Jun; 23(1):295. PubMed ID: 37264361
[TBL] [Abstract][Full Text] [Related]
12. Population attributable risk for diabetes associated with excess weight in Tehranian adults: a population-based cohort study.
Hosseinpanah F; Rambod M; Azizi F
BMC Public Health; 2007 Nov; 7():328. PubMed ID: 17999777
[TBL] [Abstract][Full Text] [Related]
13. Overtreatment and associated risk factors among multimorbid older patients with diabetes.
Baretella O; Alwan H; Feller M; Aubert CE; Del Giovane C; Papazoglou D; Christiaens A; Meinders AJ; Byrne S; Kearney PM; O'Mahony D; Knol W; Boland B; Gencer B; Aujesky D; Rodondi N
J Am Geriatr Soc; 2023 Sep; 71(9):2893-2901. PubMed ID: 37286338
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and determinants of anemia among Iranian population aged ≥35 years: A PERSIAN cohort-based cross-sectional study.
Zamani M; Poustchi H; Shayanrad A; Pourfarzi F; Farjam M; Noemani K; Ghaderi E; Mohammadkarimi V; Kahnooji M; Mansour-Ghanaei F; Rastegar A; Mousavizadeh A; Rafati S; Johari MG; Moosazadeh M; Salehifardjouneghani A; Ostadrahimi A; Mohebbi I; Khorram A; Ardakani FE; Sharafkhah M; Pasdar Y; Sadeghi A; Malekzadeh R
PLoS One; 2022; 17(2):e0263795. PubMed ID: 35139138
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment.
Noale M; Veronese N; Cavallo Perin P; Pilotto A; Tiengo A; Crepaldi G; Maggi S
Acta Diabetol; 2016 Apr; 53(2):323-30. PubMed ID: 26155958
[TBL] [Abstract][Full Text] [Related]
16. Polypharmacy among the elderly: a population-based study.
Pereira KG; Peres MA; Iop D; Boing AC; Boing AF; Aziz M; d'Orsi E
Rev Bras Epidemiol; 2017; 20(2):335-344. PubMed ID: 28832855
[TBL] [Abstract][Full Text] [Related]
17. Environmental and economics-related factors of smoking among Iranian adults aged 35-70: a PERSIAN cohort-based cross-sectional study.
Zahirian Moghadam T; Zandian H; Pourfarzi F; Poustchi H
Environ Sci Pollut Res Int; 2021 Sep; 28(33):45365-45374. PubMed ID: 33864220
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and correlates of osteoporotic fractures among type 2 diabetic patients.
Goldshtein I; Nguyen AM; dePapp AE; Ish-Shalom S; Chandler JM; Chodick G; Shalev V
Arch Osteoporos; 2018 Mar; 13(1):15. PubMed ID: 29502187
[TBL] [Abstract][Full Text] [Related]
19. Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective.
Sutaria A; Liu L; Ahmed Z
Ther Adv Cardiovasc Dis; 2016 Aug; 10(4):242-50. PubMed ID: 26920372
[TBL] [Abstract][Full Text] [Related]
20. Mediterranean diet, walking outdoors and polypharmacy in older patients with type II diabetes.
Fortes C; Mastroeni S; Tubili C; Gianni S; Pandolfo MM; Fano V
Eur J Public Health; 2021 Oct; 31(4):829-835. PubMed ID: 34499712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
